Premenstrual Syndrome Treatment Market Analysis (2024-30)

Global Premenstrual Syndrome Treatment Market Research Report: Forecast (2024-2030)

Global Premenstrual Syndrome Treatment Market Share - By Drug Type (Analgesics, Antidepressants, Oral Contraceptives, Ovarian Suppression Agents, Others (Diuretics, Herbal Supplements, etc.)), By Typ... ... ents, etc.)), By Type (Prescription, Over-the-Counter (OTC)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)), and Other Read more

Healthcare
Jul 2024
Pages 183
Report Format: PDF, Excel, PPT

Market Definition

A hormonal imbalance in women leads to premenstrual syndrome (PMS), which impacts their mental health. PMS is reflected through symptoms like stress, tension, sobbing, mood swings, etc. These problems are common in women in their monthly cycle and can be treated with PMS treatment medications such as ovarian suppression drugs, analgesics, antidepressants, and oral contraceptives. These remedies can be taken with or without a prescription and are often found in the drugstore.

Market Insights & Analysis: Global Premenstrual Syndrome Treatment Market (2024-30):

The Global Premenstrual Syndrome Treatment Market is estimated to grow at a CAGR of around 3.7% during the forecast period, i.e., 2024-30. The demand for Premenstrual Syndrome (PMS) treatment solutions has been increasing consistently across the globe in recent years. This has been primarily influenced by the adoption of unhealthy lifestyles by a large population of women across the globe, mainly in regions such as North America and Europe. Globally, instances of PMS have been observed specifically across countries that have a high working female population. This is primarily because working women are generally unable to take care of their physical and mental well-being, owing to the time constraints, which have been leading to a hormonal imbalance among them. Consequently, the symptoms of PMS have been mainly observed among working women. Further, PMS often leads to mental issues like anxiety, depression, stress, etc., which reduces the work efficiency of women. Hence, to reduce the effect of PMS on their work schedule, most women opt for PMS treatment solutions, which have been responsible for the market growth & expansion in recent years.

Report Coverage	Details
Study Period	Historical Data: 2019-22
	Base Year: 2023
	Forecast Period: 2024-29
CAGR (2024-2029)	3.7%
Regions Covered	North America: The US, Canada, Mexico
	Europe: Germany, The UK, France, Italy, Spain, Rest of Europe
	Asia-Pacific: China, Japan, Australia, South Korea, India, Rest of Asia-Pacific
	South America: Brazil, Rest of South Americ
	Middle East & Africa: The UAE, South Africa, Saudi Arabia, Rest of the Middle East & Africa
Key Companies Profiled	Bayer AG, Pfizer Inc., Zydus Cadila, Alkem Laboratories Ltd., Kobayashi Pharmaceutical Co., Ltd., Haleon Group of Companies, Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Asarina Pharma AB, Lupin, Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd. (Accord Healthcare), Ova Moon, AstraZeneca plc, and others
Unit Denominations	USD Million/Billion

Furthermore, apart from the working women population, female students in college and universities often face the issue of premenstrual syndrome in their lives. The issue among female students is highly prominent in countries such as China, Japan, Turkey, etc., because of the factors related to their lifestyle, dietary habits, and genetics. Moreover, female students often face stress situations due to academic pressure, which leads to the worsening of the symptoms of PMS among them. Also, if such a syndrome persists for a longer duration, it affects their academic performance, and hence, they prefer to adopt PMS treatment solutions to recover. Henceforth, this type of problem has also been augmenting the size & volume of the PMS treatment industry during the historical years.

Additionally, with the rising disposable incomes, women have been observed to extensively incline toward unhealthy eating & drinking habits, like consumption of alcohol, junk food, and smoking among others. These unhealthy food items have been observed to trigger hormonal imbalances among most women, which further worsens their condition of premenstrual syndrome. Hence, as the adoption of unhealthy eating habits escalates among women, the instances of PMS would also improve, which would escalate the demand for PMS treatment solutions during the forecast period.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Global Premenstrual Syndrome Treatment Market Trends & Developments
Global Premenstrual Syndrome Treatment Market Dynamics
1. Drivers
2. Challenges
Global Premenstrual Syndrome Treatment Market Hotspot & Opportunities
Global Premenstrual Syndrome Treatment Market Supply Chain Analysis
Global Premenstrual Syndrome Treatment Market Regulations and Policy
Global Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Size & Analysis
  1. By Drug Type
    1. Analgesics- Market Size & Forecast 2019-2030, USD Million
    2. Antidepressants- Market Size & Forecast 2019-2030, USD Million
    3. Oral Contraceptives- Market Size & Forecast 2019-2030, USD Million
    4. Ovarian Suppression Agents- Market Size & Forecast 2019-2030, USD Million
    5. Others (Diuretics, Herbal Supplements, etc.)- Market Size & Forecast 2019-2030, USD Million
  2. By Type
    1. Prescription- Market Size & Forecast 2019-2030, USD Million
    2. Over-the-Counter (OTC)- Market Size & Forecast 2019-2030, USD Million
  3. By Distribution Channel
    1. Hospital Pharmacies- Market Size & Forecast 2019-2030, USD Million
    2. Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
    3. Online Pharmacies- Market Size & Forecast 2019-2030, USD Million)
  4. By Region
    1. North America
    2. South America
    3. Europe
    4. The Middle East & Africa
    5. Asia-Pacific
  5. By Competition
    1. Competition Characteristics
    2. Market Share of Companies
North America Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
  2. By Type- Market Size & Forecast 2019-2030, USD Million
  3. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
  4. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
4. Canada Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
5. Mexico Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
South America Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
  2. By Type- Market Size & Forecast 2019-2030, USD Million
  3. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
  4. By Country
    1. Brazil
    2. Rest of South America
3. Brazil Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
Europe Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
  2. By Type- Market Size & Forecast 2019-2030, USD Million
  3. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
  4. By Country
    1. Germany
    2. The UK
    3. France
    4. Spain
    5. Italy
    6. Rest of Europe
3. Germany Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
4. The UK Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
5. France Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
6. Spain Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
7. Italy Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
The Middle East & Africa Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
  2. By Type- Market Size & Forecast 2019-2030, USD Million
  3. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
  4. By Country
    1. The UAE
    2. Saudi Arabia
    3. South Africa
    4. Rest of the Middle East & Africa
3. The UAE Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
4. Saudi Arabia Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
5. South Africa Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
Asia-Pacific Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
  2. By Type- Market Size & Forecast 2019-2030, USD Million
  3. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
  4. By Country
    1. China
    2. Japan
    3. Australia
    4. South Korea
    5. India
    6. Rest of Asia-Pacific
3. China Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
4. Japan Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
5. Australia Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
6. South Korea Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
7. India Premenstrual Syndrome Treatment Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
Global Premenstrual Syndrome Treatment Market Key Strategic Imperatives for Growth & Success
Competitive Outlook
1. Company Profiles
  1. Bayer AG
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Pfizer Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. Zydus Cadila
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Alkem Laboratories Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Kobayashi Pharmaceutical Co., Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Haleon Group of Companies
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Johnson & Johnson Services, Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Teva Pharmaceutical Industries Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Viatris Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Asarina Pharma AB
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  11. Lupin
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  12. Sun Pharmaceutical Industries Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  13. Intas Pharmaceuticals Ltd. (Accord Healthcare)
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  14. Ova Moon
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  15. AstraZeneca plc
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  16. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying